20
Sat, Apr
44 New Articles

Brandl & Talos and Herbst Kinsky Advises Series D Investors on Financing Round for Themis Bioscience

Brandl & Talos and Herbst Kinsky Advises Series D Investors on Financing Round for Themis Bioscience

Austria
Tools
Typography
  • Smaller Small Medium Big Bigger
  • Default Helvetica Segoe Georgia Times

Brandl & Talos has advised an investor consortium of Farallon Capital, Adjuvant Capital, Global Health Investment Fund, Hadean Ventures, Omnes Capital, Ventech, Wellington Partners Life Sciences, and High-Tech Grunderfonds.on Themis Bioscience's EUR 40 million Series D financing round. Herbst Kinsky advised Themis Bioscience, and Baker McKenzie advised another investor, MSD, on the deal.

According to Brandl & Talos, the funds are intended to finance a study for a vaccine against the Chikungunya virus, a tropical disease transmitted by mosquitoes, and to develop a new vaccine for oncology and infectious diseases.

The Brandl & Talos team was led by Partner Roman Rericha and Attorney-at-Law Markus Arzt, supported by Attorney Sabine Konrad and Associate Christina Bernhart.

The Baker McKenzie team was led by Partner Eva-Maria Segur-Cabanac. 

The Herbst Kinsky team was led by Attorney-at Law Florian Steinhart, supported by Associates Magdalena Wagner and Alexander Holler. 

Herbst Kinsky also advised Themis Bioscience on its Series C financing round back in 2018 (as reported by CEE Legal Matters on January 16, 2018) and on its Series B financing round back in 2015 (as reported on December 6, 2016).

Baker McKenzie at a Glance

Baker McKenzie brings insight and foresight to clients across more than 70 global offices. Our team of 13,000 people, including over 6,500 lawyers, works alongside our clients to drive growth that is both sustainable – and inclusive. The global business community is more interconnected than ever before. Opportunities and risks spill across different markets, sectors and areas of law, so a connected perspective is essential in delivering business objectives while mitigating risk. Our integrated client solutions provide seamless advice, underpinned by deep practice and sector expertise, as well as first-rate local market knowledge.

In the Central and Eastern European (CEE) region, Baker McKenzie's expansion remains steadfast, with a thriving team of over legal professionals. Our footprint extends across six offices in Austria, the Czech Republic, Hungary, Poland, Türkiye, and Ukraine. As part of our global network, coupled with well-established partnerships throughout the entire CEE landscape, we proudly stand as one of the foremost international law firms in this dynamic territory. Our reputation as a premier business law firm in CEE is a testament to our extensive experience in advising on a multitude of prestigious projects and nurturing enduring client relationships.

Firm's website.